MRI-based prediction of DNA methylation grade in IDH-mutant astrocytomas using qualitative imaging features and tumor volumetrics.

purposeHistopathological grading of IDH-mutant astrocytomas demonstrates limited prognostic accuracy. However, DNA methylation subclassification has demonstrated improved prognostication beyond histological grading. This study aimed to investigate the associations between imaging features, tumor volumetric data, and DNA methylation grade in IDH-mutant astrocytomas.

methodsWe analyzed imaging features and volumetric data for 72 patients diagnosed with IDH-mutant astrocytomas, who underwent preoperative MRI and DNA methylation profiling. VASARI features and multicompartmental volumetrics were evaluated. Logistic regression was used to identify imaging predictors of methylation subclass, WHO histologic grade, copy number variation (CNV), and CDKN2A/B homozygous deletion. Univariable and multivariable Cox proportional hazard models were also developed to assess these variables' influence on overall survival and progression-free survival.

resultsPatients were classified into 27 methylation high-grade (A_IDH_HG) and 45 methylation low-grade (A_IDH_LG) tumors. Tumor volumes and proportions varied by methylation grade, CNV status, and WHO histologic grade, but not by CDKN2A/B status. Imaging features distinguished methylation subclasses with 75% accuracy (AUC = 0.77). Methylation high-grade subclass was associated with imaging features such as midline crossing, ependymal extension, and poorly defined enhancing margins. Predictive performance for WHO histologic grade, CNV status, and CDKN2A/B deletion was moderate (AUC = 0.67, 0.69, and 0.65, respectively). Methylation grade, CDKN2A/B status, VASARI features, and proportions of edema and non-contrast enhancing tumor were significantly associated with survival.

conclusionMRI-derived imaging features facilitate noninvasive prediction of DNA methylation subclass in IDH-mutant astrocytomas.